Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $29.50

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $29.50.

Several equities research analysts have issued reports on XRAY shares. Evercore ISI cut their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th.

DENTSPLY SIRONA Stock Up 2.3 %

Shares of NASDAQ:XRAY opened at $19.64 on Thursday. The company has a 50-day simple moving average of $22.97 and a 200 day simple moving average of $24.93. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period last year, the business posted $0.49 earnings per share. Research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in XRAY. UniSuper Management Pty Ltd increased its stake in DENTSPLY SIRONA by 1,153.6% in the first quarter. UniSuper Management Pty Ltd now owns 26,126 shares of the medical instruments supplier’s stock valued at $867,000 after acquiring an additional 24,042 shares during the last quarter. Advisors Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA by 99.3% during the first quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier’s stock worth $483,000 after buying an additional 7,248 shares during the last quarter. Toronto Dominion Bank grew its stake in shares of DENTSPLY SIRONA by 11.0% during the first quarter. Toronto Dominion Bank now owns 99,358 shares of the medical instruments supplier’s stock worth $3,298,000 after buying an additional 9,824 shares during the last quarter. Gabelli Funds LLC grew its stake in shares of DENTSPLY SIRONA by 0.4% during the first quarter. Gabelli Funds LLC now owns 217,000 shares of the medical instruments supplier’s stock worth $7,202,000 after buying an additional 800 shares during the last quarter. Finally, Lazard Asset Management LLC grew its stake in shares of DENTSPLY SIRONA by 3.2% during the first quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier’s stock worth $135,440,000 after buying an additional 126,351 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.